Key takeaways
- Emerging markets account for a disproportionate share of SmartGARP’s ‘best ideas’
- Strong returns have not erased emerging markets’ valuation advantage
- China still offers more compelling opportunities than India
At Artemis, we pride ourselves on having the courage to be different – on following the evidence rather than the crowd. Our funds reflect that. And one distinctive feature our global equity strategies share is their overweight exposure to emerging markets.
That isn’t due to any wilful contrarianism on our part. It simply reflects our willingness to take a clear view on where the best opportunities are.
Almost half of SmartGARP’s ‘best ideas’ globally are in emerging markets
SmartGARP, Artemis’ stock-screening tool, measures around 7,000 companies around the world for a range of financial characteristics, trying to identify instances where share prices do not reflect the strength of a company’s fundamentals.
Search Panacea’s library of insight, technical commentary and adviser resources to quickly find guidance on client and regulatory questions.